📋 Tender Overview
Contract awarded for Bevacizumab lot-0001, title: pharm-2025-829 - 1, description: the market concerns the supplies of the pharmaceutical specialty containing the active ingredient 'bevacizumab' for injection in 'ready to use' vials of 100mg and 400mg. estimated value excluding vat: 503440.00 eur.Bevacizumab